These findings “beg the question of what might happen if an antibody like this were used in an asymptomatic population when they had very little tau burden,” said Washington University ...
Both GDNF and US-CM upregulated claudin-5 and VE-cadherin expression, which were attenuated by anti-GDNF antibody and GDNF signaling inhibitors. GDNF increased claudin-5 expression via the ...
The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. The company was spun ...
Ueda is holding an expandable toy that he uses to demonstrate how the company’s computationally designed Antibody Cages work. (GeekWire Photo / Alan Boyle) Three weeks after University of ...
EMT markers (E-cadherin, N-cadherin, P120 catenin (P120ctn), and vimentin ... Then, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 1 hour at room ...
"Novel antibody platform tackles viral mutations." ScienceDaily. www.sciencedaily.com / releases / 2024 / 10 / 241023130922.htm (accessed November 16, 2024). Explore More ...
About clesrovimab (MK-1654) Clesrovimab (MK-1654) is an investigational, extended half-life monoclonal antibody (mAb) developed as a passive immunization for the prevention of RSV. Clesrovimab is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback